Autres langues Balaxi Pharmaceuticals Limited

Actions

BALAXI

INE618N01022

Produits pharmaceutiques

Marché Fermé - NSE India S.E. 13:05:07 09/10/2026			Varia. 5j.	Varia. 1 janv.
22,33 ^INR	+1,09%		-0,04%	-16,90%

05/08	Balaxi Pharmaceuticals Limited publie ses résultats pour le premier trimestre clos le 30 juin 2026	CI
29/05	Balaxi Pharmaceuticals Limited publie ses résultats pour le quatrième trimestre et l'exercice clos le 31 mars 2026	CI

Autres langues

05/08	Balaxi Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
29/05	Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
28/01	Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
05/08/25	Balaxi Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
30/05/25	Balaxi Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2025
10/02/25	Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024
07/11/24	Balaxi Pharmaceuticals Limited Approves Appointment of Akshita Surana as Non- Executive Independent Director
05/11/24	Balaxi Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
05/11/24	Balaxi Pharmaceuticals Limited Announces Company Secretary Changes
02/08/24	Balaxi Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2024
29/05/24	Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
09/05/24	Balaxi Pharmaceuticals Limited Appoints Mahesh Inani as the Compliance Officer
08/05/24	Balaxi Pharmaceuticals Limited Announces Resignation of Purnima Singh Kamble as Independent Director
04/05/24	Balaxi Pharmaceuticals Limited Announces Resignation of Udayan Shukla as Company Secretary and Compliance Officer
14/02/24	Balaxi Pharmaceuticals Limited Incorporates New Wholly Owned Subsidiary in Chile
09/02/24	Balaxi Pharmaceuticals Limited Announces Update on Company's Pharmaceutical Formulation Plant
09/02/24	Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
02/11/23	Balaxi Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
01/10/23	Balaxi Pharmaceuticals Limited completed the acquisition of Balaxi Healthcare Ecuador S.A.S.
03/08/23	Balaxi Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
03/08/23	Balaxi Pharmaceuticals Limited agreed to acquire Balaxi Healthcare Ecuador S.A.S. for $0.04 million.
29/05/23	Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
01/02/23	Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
10/01/23	Balaxi Pharmaceuticals : Certificate under SEBI (Depositories and Participants) Regulations, 2018
05/11/22	Balaxi Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022